For Immediate Release

Chicago, IL – July 30, 2009 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Ness Technologies (NSTC), Accenture Ltd. (ACN), International Business Machines Corp. (IBM), Hewlett Packard (HPQ) and Computer Sciences Corporation (CSC).

Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=5513

Here are highlights from Wednesday’s Analyst Blog:

Weak Results at Ness Tech

Today, Ness Technologies (NSTC) reported second quarter pro forma earnings of $0.09 per share, $0.02 better than the consensus estimate of $0.07 but down 64.0% from $0.25 in the year-ago period, and was well below our estimate of

...

Today, Ness Technologies (NSTC) reported second quarter pro forma earnings of $0.09 per share, $0.02 better than the consensus estimate of $0.07 but down 64.0% from $0.25 in the year-ago period, and was well below our estimate of $0.14. Revenues fell 19.6% year-over-year to $137.2 million, slightly below the consensus estimate of $139.5 million and below our optimistic estimate of $150.0 million. Almost half of the revenue decrease was due to unfavorable foreign currency translation effects for non-dollar revenues, with the remainder attributable mainly to slower sales in the company’s System Integration and Application Development segment, which fell 17.7% year-over-year impacted by the worldwide economic slowdown. Revenue also declined as Software Distribution segment underperformed significantly in the quarter and fell 61.6%, resulting in an operating loss for the segment, partially offset by a moderate 3.8% increase in the Software Product Engineering segment. Non-GAAP gross margin for ...

For Immediate Release

Chicago, IL - March 31, 2009 - Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Ness Technologies (NSTC), American Capital Agency Corp (AGNC), Biogen Idec (BIIB), Sohu.com Inc (SOHU) and Cornerstone Therapeutics Inc (CRTX).

Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=4579.

Here are highlights from Monday's Analyst Blog:

Ness Tech with More Downside

Ness Technologies (NSTC) is a small player in the IT services market. The company posted mixed 4Q08 results, with revenue below expectation but in line EPS.

The company's Application Development and Software Product Engineering segment performed very well in 4Q08. However,

...

Ness Technologies (NSTC) is a small player in the IT services market. The company posted mixed 4Q08 results, with revenue below expectation but in line EPS.The company's Application Development and Software Product Engineering segment performed very well in 4Q08. However, Ness has forecasted lower-than-expected 2009 results, hurt by a slowdown at its U.S. financial services and NessPRO software distribution businesses.Challenges remain with an uncertain global economy, severe pricing pressure and volatile equity markets. We believe there is risk that the company will not be able to reach its target. We therefore maintain our Sell rating on NSTC shares and lower our 6-month target price to $2.30.Anita Mohata contributed to this report. Read the full analyst report on "NSTC"Zacks Investment Research

Ness Technologies (NSTC) is a small player in the IT services market. The company has undergone significant changes over the past year, with turnover in its senior management team and choppy results during 2007.

Ness posted lower-than-expected 3Q08 results, hurt mainly by a slowdown at its U.S. financial services and NessPRO software distribution businesses. Moreover, challenges remain with an uncertain global economy and volatile equity market.

We believe there is risk that the company will not be able to reach its target and we have low confidence on the company's current estimates. We are lowering our estimates for 2008 and 2009, and maintain our Sell rating on NSTC shares with our six-month target price of $4.00

"NSTC" Free Stock Analysis: Buy? Sell? Hold?Zacks Investment Research